The Best Experience Meets the Most Advanced Portfolio

LEARN MORE

Long-lasting and clinically proven solutions for bladder and bowel control

Axonics aspires to be the global leader in incontinence therapies by providing customer-centric solutions to improve the quality of life for patients suffering from urinary and bowel dysfunction.

OAB, FI, SUI solutions with Axonics SNM and Bulkamid
Axonics SNM

Experience Choice WITHOUT COMPROMISE

Rechargeable SNM System

Axonics R20 is an easy-to-use system that offers your patients a long-lasting therapy designed to last 20+ years, and only requires recharging every 6 to 10 months.*

*Recharge interval depends on therapy settings

LEARN MORE
Axonics5I5

Recharge-Free SNM System

With a 10 to 20 year battery life*, Axonics F15 has redefined the therapy experience for your patients, offering a long-lived and TRULY recharge-free solution.

*Depending on therapy settings

LEARN MORE

The Bulkamid Advantage

Unique Composition

Homogenous hydrogel consisting of 97.5% water and 2.5% cross-linked polyacrylamide3.

Precision Delivery System

Allows for reproducible placement of the Bulkamid cushions under direct vision.

Efficacious, Durable, Safe

92% of women report being cured or improved at 12 months3, with durability demonstrated at seven years4 and no serious adverse events5.
LEARN MORE

Experience The Difference.

GET STARTED TODAY

Your Practice. Our Priority.

axonics ambassador We have ambassador volunteers who are Axonics patients ready to speak with your patients regarding their experience with Axonics Therapy. Get Connected

Resources for reimbursement

Axonics provides coding and billing resources and support

Access resources

Sign up to get the latest news

Stay up-to-date with recent happenings surrounding Axonics by joining our email list

SIGN UP

References:

  1. Recharge interval depends on therapy settings
  2. Pezzella A, McCrery R, Lane F, et al. Two-year outcomes of the ARTISAN-SNM study for the treatment of urinary urgency incontinence using the Axonics rechargeable sacral neuromodulation system [published online ahead of print, 2021 Jan 28]. Neurourol Urodyn. 2021;10.1002/nau.24615. doi:10.1002/nau.24615
  3. Brosche T, et al. Journal of Neurology and Urodynamics. 2021
  4. Dwyer et al., “Voice your choice”: A study of women’s choice of surgery for primary stress urinary incontinence. International Urogynecology Journal (2020) 31:769-777
  5. Itkonen Freitas et al. Journal of Urology 2020

Questions?

We are here to help answer any questions you may have about Axonics Therapy.

CONTACT US